Michelle E. Howard, PhD, DABR, has received an Aiming For A Cure Foundation Grant to support research focused on developing precision therapies for pediatric high-grade gliomas.

Medical student Asya Lengel earned the award for an oral research presentation mentored by Doug Spitz, PhD.

James D. Byrne, MD, PhD, has been promoted to Associate Professor with tenure in the University of Iowa Department of Radiation Oncology.

Radiation Therapy student Lillian Wischmeyer was recognized with two scholarships at the University of Iowa Radiation Sciences Scholarship Reception.

Radiation Oncology nurse Linda Crowley was recognized with the Silver Level Professional Recognition Program Award for her dedication to nursing, patient car e, and her colleagues.

Radiation Oncology nurses Jessica Williams and Linda Crowley were nominated by patients for The DAISY Award for Extraordinary Nurses in recognition of their compassionate, supportive care.

University of Iowa Health Care radiation oncology was featured in a recent KWQC-TV6 segment examining the role of local treatment access in cancer care across the Quad Cities.

Andrean Simons-Burnett, PhD, earns a $50,000 AYA Cancer Program grant to advance head and neck cancer research for patients with Fanconi anemia.

James Byrne, MD, PhD, wins top prize at the 2026 V Foundation V Scholar Summit collaborative challenge, earning $10,000 in research funding.

Carryn Anderson, MD, Clinical Professor of Radiation Oncology at the University of Iowa, receives the Excellence in Clinical Coaching Award from the GME Office.

UI Radiation Oncology faculty Garry Buettner, PhD, and Bryan Allen, MBA, MD, PhD, are featured in Medscape on the growing scientific case for high-dose vitamin C in cancer treatment.

Blake Smith, PhD wins a national AAPM award for his published research on motion management commissioning for the UI's Elekta Unity MR-Linac.

Blake Smith, PhD, receives a $40,000 ACS seed grant through Holden Comprehensive Cancer Center to study radiobiologic risk in pediatric proton therapy patients.

James Byrne named a finalist for the 2026 BioInnovation Institute & Science Prize for Innovation